Fingerprint
Dive into the research topics of 'The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy
M. O. Holmstrom, E. Martinenaite, S. M. Ahmad, O. Met, C. Friese, L. Kjaer, C. H. Riley, P. thor Straten, I. M. Svane, H. C. Hasselbalch, M. H. Andersen